- 5 Résultats
prix le plus bas: € 74,89, prix le plus élevé: € 160,49, prix moyen: € 112,14
1
Minimal Residual Disease and Circulating Tumor Cells in Breast Cancer - Michail Ignatiadis; Christos Sotiriou; Klaus Pantel
Commander
sur Springer.com
€ 160,49
CommanderLien sponsorisé
Michail Ignatiadis; Christos Sotiriou; Klaus Pantel:

Minimal Residual Disease and Circulating Tumor Cells in Breast Cancer - nouveau livre

ISBN: 9783642281600

This important book provides up-to-date information on a series of topical issues relating to the approach to minimal residual disease in breast cancer patients. It first explains how the… Plus…

new in stock. Frais d'envoizzgl. Versandkosten., Livraison non-comprise
2
Minimal Residual Disease and Circulating Tumor Cells in Breast Cancer (Recent Results in Cancer Research Book 195) (English Edition)
Commander
sur amazon.de
€ 74,89
Envoi: € 0,001
CommanderLien sponsorisé
Minimal Residual Disease and Circulating Tumor Cells in Breast Cancer (Recent Results in Cancer Research Book 195) (English Edition) - nouveau livre

2012, ISBN: 9783642281600

Springer, Kindle Ausgabe, Auflage: 2012, 456 Seiten, Publiziert: 2012-04-23T00:00:00.000Z, Produktgruppe: Digital Ebook Purchas, Chirurgie, Medizin, Kategorien, Bücher, Geburtshilfe & Per… Plus…

Frais d'envoiJetzt als Download verfügbar. (EUR 0.00) Amazon Media EU S.à r.l.
3
Minimal Residual Disease and Circulating Tumor Cells in Breast Cancer (Recent Results in Cancer Research Book 195)
Commander
sur amazon.co.uk
£ 94,99
(environ € 111,35)
Envoi: € 5,251
CommanderLien sponsorisé
Minimal Residual Disease and Circulating Tumor Cells in Breast Cancer (Recent Results in Cancer Research Book 195) - nouveau livre

2012

ISBN: 9783642281600

Editor: Ignatiadis, Michail, Editor: Sotiriou, Christos, Editor: Pantel, Klaus, Springer, Kindle Edition, Auflage: 2012, 456 Seiten, Publiziert: 2012-04-23T00:00:00.000Z, Produktgruppe: D… Plus…

Frais d'envoiAvailable for download now. (EUR 5.25) Amazon Media EU S.à r.l.
4
Minimal Residual Disease and Circulating Tumor Cells in Breast Cancer - Michail Ignatiadis; Christos Sotiriou; Klaus Pantel
Commander
sur lehmanns.de
€ 106,99
Envoi: € 0,001
CommanderLien sponsorisé
Michail Ignatiadis; Christos Sotiriou; Klaus Pantel:
Minimal Residual Disease and Circulating Tumor Cells in Breast Cancer - nouveau livre

2012, ISBN: 9783642281600

eBooks, eBook Download (PDF), 2012, [PU: Springer Berlin], Seiten: 254, Springer Berlin, 2012

Frais d'envoiDownload sofort lieferbar. (EUR 0.00)
5
Minimal Residual Disease and Circulating Tumor Cells in Breast Cancer - Michail Ignatiadis; Christos Sotiriou; Klaus Pantel
Commander
sur lehmanns.de
€ 106,99
Envoi: € 0,001
CommanderLien sponsorisé
Michail Ignatiadis; Christos Sotiriou; Klaus Pantel:
Minimal Residual Disease and Circulating Tumor Cells in Breast Cancer - nouveau livre

2012, ISBN: 9783642281600

eBooks, eBook Download (PDF), 2012, [PU: Springer Berlin], Springer Berlin, 2012

Frais d'envoiDownload sofort lieferbar. (EUR 0.00)

1Comme certaines plateformes ne transmettent pas les conditions d'expédition et que celles-ci peuvent dépendre du pays de livraison, du prix d'achat, du poids et de la taille de l'article, d'une éventuelle adhésion de la plateforme, d'une livraison directe par la plateforme ou via un prestataire tiers (Marketplace), etc. il est possible que les frais de livraison indiqués par eurolivre ne correspondent pas à ceux de la plateforme qui propose l'article.

Données bibliographiques du meilleur livre correspondant

Détails sur le livre

Informations détaillées sur le livre - Minimal Residual Disease and Circulating Tumor Cells in Breast Cancer


EAN (ISBN-13): 9783642281600
ISBN (ISBN-10): 3642281605
Date de parution: 2012
Editeur: Springer Berlin
253 Pages
Langue: eng/Englisch

Livre dans la base de données depuis 2007-08-16T08:57:27+02:00 (Zurich)
Page de détail modifiée en dernier sur 2024-02-11T15:46:25+01:00 (Zurich)
ISBN/EAN: 9783642281600

ISBN - Autres types d'écriture:
3-642-28160-5, 978-3-642-28160-0
Autres types d'écriture et termes associés:
Auteur du livre: christ klaus, pant, pantel, michail, ign, christos, sotiriou
Titre du livre: res, min, mini, cancer, tum, cel, beyond the minimal, residu, minim, tumor


Données de l'éditeur

Auteur: Michail Ignatiadis; Christos Sotiriou; Klaus Pantel
Titre: Recent Results in Cancer Research; Minimal Residual Disease and Circulating Tumor Cells in Breast Cancer
Editeur: Springer; Springer Berlin
254 Pages
Date de parution: 2012-04-23
Berlin; Heidelberg; DE
Imprimé / Fabriqué en
Langue: Anglais
106,99 € (DE)
110,00 € (AT)
130,00 CHF (CH)
Available
XIV, 254 p.

EA; E107; eBook; Nonbooks, PBS / Medizin/Klinische Fächer; Onkologie; Verstehen; Breast cancer; Circulating nucleic acids; Circulating tumor cells; Micrometastasis; Minimal residual disease; surgical oncology; C; Oncology; Gynecology; Surgical Oncology; Pathology; Cancer Research; Oncology; Gynecology; Cancer Therapy; Pathology; Cancer Biology; Medicine; Gynäkologie und Geburtshilfe; Pathologie; BB

Minimal residual disease and circulating tumor cells in breast cancer: Open questions for research.- Minimal residual disease and breast cancer metastasis.- Self-seeding in cancer.- Microenvironments dictating tumor cell dormancy.- Technologies for circulating tumor cell (CTC) and disseminated tumor cell (DTC) detection and characterization.- Immunomagnetic separation technologies.- Microfluidic technologies for the isolation of CTCs.- EPISPOT assay: Detection of viable disseminating tumor cells in solid tumor patients.- Advances in optical technologies for rare cell detection and characterization.- Size-based enrichment technologies for circulating tumor cell (CTC) detection and characterization.- Emerging technologies for CTC detection based on depletion of normal cells.- Molecular assays for the detection and characterization of CTCs.- Multiplex molecular analysis of CTCs.- Other blood-based biomarkers.- Circulating DNA and next generation sequencing.- Circulating microRNAs as non-invasive biomarkers in breast cancer.- Circulating endothelial cells and circulating endothelial progenitors.- Disseminated tumor cells (DTCs) and circulating tumor cells (CTCs) in breast cancer clinical research and practice.- Bone marrow DTCs.- CTCs in primary breast cancer.- CTCs in early breast cancer.- CTCs in metastatic breast cancer.- HER2-positive DTCs/CTCs in breast cancer.- DTCs and CTCs in breast cancer – 5 decades later.- Drug and circulating tumor cell co-development.- Challenges in drug and biomarker co-development.- Challenges and opportunities in the use of CTCs for companion diagnostic development.

Provides up-to-date information on topical issues concerning minimal residual disease in breast cancer patients

Appraises the technologies available for detection and characterization of circulating and disseminated tumor cells (CTCs/DTCs)

Discusses the relevance of CTCs and DTCs in breast cancer clinical research and practice, and the role of other blood-based biomarkers

Includes supplementary material: sn.pub/extras

Provides up-to-date information on topical issues concerning minimal residual disease in breast cancer patients

Appraises the technologies available for detection and characterization of circulating and disseminated tumor cells (CTCs/DTCs)

Discusses the relevance of CTCs and DTCs in breast cancer clinical research and practice, and the role of other blood-based biomarkers



< pour archiver...